Aprogen Pharma rises 8.16% amid vaccine/diagnostic reagent/quarantine themes (including H1N1, AI, etc.) trending up

On the 16th, the vaccine/diagnostic reagent/epidemic prevention (including novel flu, AI, etc.) theme rose by 3.04% compared to the previous day, showing strength. Among the related stocks, Aprogen Pharmaceuticals, which is attracting attention, surged by 8.16% compared to the previous day. Aprogen Pharmaceuticals is known as a pharmaceutical company focused on antibiotics.

[Graph] Major stock price changes in the vaccine/diagnostic reagent/epidemic prevention (including novel flu, AI, etc.) theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Aprogen Pharmaceuticals’ quant financial score is 36.23 points, ranking 16th within the vaccine/diagnostic reagent/epidemic prevention (including novel flu, AI, etc.) theme. Its growth and stability scores are higher than the average of other stocks in the theme. This indicates that compared to other stocks in the theme, Aprogen Pharmaceuticals has a relatively fast increase in sales and net profit, and also shows good responsiveness to changes in domestic and international economic environments.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.